Biomaterials, 2014 · DOI: 10.1016/j.biomaterials.2014.06.051 · Published: October 1, 2014
The study explores the use of biomaterials to reduce scar formation in the central nervous system after injury. It investigates whether thrombin inhibitors delivered locally can mitigate the negative effects of blood-borne proteins after spinal cord injury. The research focuses on using PLGA microspheres and Pluronic F-127 hydrogels for sustained delivery of thrombin inhibitors like heparin and hirudin.
Biomaterials designed for prolonged release of thrombin inhibitors hold promise for mitigating scarring and promoting regenerative therapies in the CNS.
PLGA/F-127 hydrogels can be used for controlled delivery of therapeutic peptides like hirudin to specific sites in the spinal cord.
Hirudin delivery post-injury can accelerate motor function recovery and increase oligodendrocyte populations.